Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)

Autor: Sandra N. Slagter, Hanneke J C M Wouters, Bruce H. R. Wolffenbuttel, Melanie M. van der Klauw, Anneke C. Muller Kobold
Přispěvatelé: Life Course Epidemiology (LCE), Lifestyle Medicine (LM), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Questionnaires
Male
Pediatrics
endocrine system diseases
Epidemiology
Peptide Hormones
Thyroid Gland
Thyrotropin
Thyroid Function Tests
Biochemistry
Cohort Studies
0302 clinical medicine
Endocrinology
Medicine and Health Sciences
030212 general & internal medicine
POPULATION
Subclinical infection
Netherlands
Thyroid
Aged
80 and over

RISK
education.field_of_study
Multidisciplinary
medicine.diagnostic_test
OF-LIFE
Middle Aged
PREVALENCE
medicine.anatomical_structure
Research Design
CARDIOVASCULAR-DISEASE
Medicine
Triiodothyronine
Female
Anatomy
hormones
hormone substitutes
and hormone antagonists

medicine.drug
Cohort study
Research Article
Adult
medicine.medical_specialty
Thyroid Hormones
endocrine system
Adolescent
Endocrine Disorders
Science
Population
Levothyroxine
030209 endocrinology & metabolism
Endocrine System
Research and Analysis Methods
Thyroid function tests
03 medical and health sciences
Young Adult
MORBIDITY
Thyroid-stimulating hormone
HEALTH-RELATED QUALITY
medicine
Humans
education
Thyroid-Stimulating Hormone
Aged
Survey Research
business.industry
MORTALITY
Biology and Life Sciences
Thyroid Diseases
Hormones
DYSFUNCTION
Age Groups
HYPOTHYROIDISM
People and Places
Population Groupings
business
Hormone
Zdroj: PLoS ONE, 15(11):0242795, 1-17. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0242795 (2020)
ISSN: 1932-6203
Popis: Background Thyroid hormone plays a pivotal role in human metabolism. In epidemiologic studies, adequate registration of thyroid disorders is warranted. We examined the prevalence of thyroid disorders, reported thyroid medication use, thyroid hormone levels, and validity of thyroid data obtained from questionnaires in the Lifelines Cohort Study. Methods We evaluated baseline data of all 152180 subjects (aged 18–93 years) of the Lifelines Cohort Study. At baseline, participants were asked about previous thyroid surgery and current and previous thyroid hormone use. At follow-up (n = 136776, after median 43 months), incident thyroid disorders could be reported in an open, non-structured question. Data on baseline thyroid hormone measurements (TSH, FT4 and FT3) were available in a subset of 39935 participants. Results Of the 152180 participants, mean (±SD) age was 44.6±13.1 years and 58.5% were female. Thyroid medication was used by 4790 participants (3.1%); the majority (98.2%) used levothyroxine, and 88% were females. 59.3% of levothyroxine users had normal TSH levels. The prevalence of abnormal TSH levels in those not using thyroid medication was 10.8%; 9.4% had a mildly elevated (4.01–10.0 mIU/L), 0.7% had suppressed (10.0 mIU/L) TSH levels. Over 98% of subjects with TSH between 4 and 10 mIU/L had normal FT4. Open text questions allowing to report previous thyroid surgery and incident thyroid disorders proved not to be reliable and severely underestimated the true incidence and prevalence of thyroid disorders. Conclusions Undetected thyroid disorders were prevalent in the general population, whereas the prevalence of thyroid medication use was 3.1%. Less than 60% of individuals using levothyroxine had a normal TSH level. The large group of individuals with subclinical hypothyroidism (9.4%) offers an excellent possibility to prospectively follow the natural course of this disorder. Both structured questions as well as linking to G.P.’s and pharmacists’ data are necessary to improve the completeness and reliability of Lifelines’ data on thyroid disorders.
Databáze: OpenAIRE